Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
1.610
-0.180 (-10.06%)
At close: Nov 14, 2025, 4:00 PM EST
1.730
+0.120 (7.45%)
After-hours: Nov 14, 2025, 7:59 PM EST
Senti Biosciences Market Cap
Senti Biosciences has a market cap or net worth of $42.12 million as of November 14, 2025. Its market cap has increased by 325.84% in one year.
Market Cap
42.12M
Enterprise Value
60.00M
1-Year Change
325.84%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since May 26, 2021, Senti Biosciences's market cap has decreased from $256.04M to $42.12M, a decrease of -83.55%. That is a compound annual growth rate of -33.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 42.12M | 161.50% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | 256.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.86B |
| Johnson & Johnson | 470.41B |
| AbbVie | 410.55B |
| UnitedHealth Group | 301.21B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.65B |
| Abbott Laboratories | 224.77B |